DDAVP in Von Willebrand's disease: Repeated administration and the behaviour of the bleeding time-Reference-Cited by-同舟云学术

DDAVP in Von Willebrand's disease: Repeated administration and the behaviour of the bleeding time

Published:1978-12 Issue:6 Volume:13 Page:1119-1123
ISSN:0049-3848
Container-title:Thrombosis Research
language:en
Short-container-title:Thrombosis Research

Author:

Theiss Wolfram,Schmidt Georg

Publisher

Elsevier BV

Subject

Hematology

Reference16 articles.

1. The release of plasminogen activator and factor VIII to lysine vasopressin, arginine vasopressin, 1-desamino-8-d-arginine vasopressin, angiotensin and oxytocin in man;Cash;Brit. J. Haematol.,1974

2. Mechanism of plasminogen activator and factor VIII increase after vasoactive drugs;Mannucci;Brit. J. Haematol.,1975

3. Studies on the prolonged bleeding time in von Willebrand's disease;Mannucci;J. Lab. Clin. Med.,1976

4. 1-deamino-8-D-arginine vasopressin: a new pharmacological approach to the management of haemophilia and von Willebrand's disease;Mannucci;Lancet,1977

5. D.D.A.V.P. in haemophilia;Lowe;Lancet,1977

Cited by 30 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. IN MEMORY OF ERIK JORPES;Scandinavian Journal of Haematology;2009-04-24

2. The Release of Plasminogen Activator and Factor VIII after Injection of DDAVP in Healthy Volunteers and in Patients with von Willebrand's Disease;Scandinavian Journal of Haematology;2009-04-24

3. von Willebrand disease (VWD): evidence-based diagnosis and management guidelines, the National Heart, Lung, and Blood Institute (NHLBI) Expert Panel report (USA);Haemophilia;2008-03

4. Desmopressin in Mild Hemophilia A: Indications, Limitations, Efficacy, and Safety;Seminars in Thrombosis and Hemostasis;2003

5. Desmopressin (DDAVP) in Bleeding Disorders of Childhood;Seminars in Thrombosis and Hemostasis;1998-12